A Study of ZT-01 on Nighttime Hypoglycemia in Type 1 Diabetes
Phase 2
186
about 3.8 years
18–75
26 sites in CA, FL, GA +11
What this study is about
This trial is testing a treatment called ZT-01 to see if it helps prevent nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use a continuous glucose monitor and take ZT-01 at different doses, or a placebo, for two periods of four weeks each. The goal is to determine if ZT-01 lowers the number of hypos happening at night and what its effects are on blood sugar levels.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take ZT-01, 15 mg
- 3.Take ZT-01, 22 mg
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Incidence and severity of adverse events (AEs)
Endocrinology